|
Pshenichnikova I.I., Zakharova I.N., Borzakova S.N., Pupykina V.V., Osmanov I.M.
Ezetimibe in the treatment of dyslipidemia in children and adolescents with types 1 and 2 diabetes mellitus: efficacy and safety
|
№7 / 2025
|
|
O.D. Ostroumova, S.V. Litvinova, A.I. Kochetkov, N.A. Plotnikova, M.V. Klepikova, S.S. Eremina, S.V. Cheremushkin
Nonalcoholic fatty liver disease combined with dyslipidemia: the role of ursodeoxycholic acid in complex therapy
|
№1 / 2025
|
|
Litvinova S.V., Kochetkov A.I., Sinitsyna I.I., Ostroumova O.D.
Omega-3 PUFA as a basic element of therapy for patients with hypertriglyceridemia
|
№9 / 2024
|
|
Gorban V.V., Gerasimenko I.A., Kovrigina I.V., Kameneva E.S., Gorban E.V.
Realities of complex therapy of lipitension in comorbid patients at the outpatient stage
|
№6 / 2024
|
|
Ostroumova O.D., Telkova S.S., Dubinina A.V., Klepikova M.V., Kochetkov A.I.
Non-alcoholic fatty liver disease as a trigger of polymorbidity. Is there a way out of the impasse?
|
№4 / 2024
|
|
D.I. Sadykova, A.A. Kamalova, R.F. Rakhmaeva, T.P. Makarova, Yu.S. Melnikova, L.F. Galimova, E.S. Slastnikova, A.A. Mustafaeva, M.A. Petrova, A.A. Garipova, Yu.A. Kalistratova, A.V. Shtyrkova, S.А. Sеnеk
Regional experience with universal screening for total cholesterol in children
|
№4-5 / 2023
|
|
S.S. Brovkina, I.S. Dzherieva, N.I. Volkova, Z.A. Goncharova, I.B. Reshetnikov
A prospective cohort study of the association of MTNR1B, MTNR1A polymorphic gene variants with metabolic and sleep disorders during glucocorticoid therapy in patients with multiple sclerosis
|
№3 / 2023
|
|
E.V. Biryukova, M.V. Shinkin, I.A. Morozovа
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
|
№3 / 2023
|
|
I.M. Abramova, K.V. Azizova, O.D. Dygun, A.D. Orlovskaya
Replacement therapy of subclinical hypothyroidism in patients with various stages of chronic kidney disease
|
№4 / 2022
|
|
M.V. Malykh (1), K.A. Nikolskaya (1), L.V. Vinokurova (1), K.A. Lesko (1), N.V. Boyko (1), N.A. Savenkova (1), A.V. Andrianov (1), D.S. Bordin (1, 2, 3), E.A. Dubtsova (1)
Hypertriglyceridemia-induced pancreatitis: a clinical case
|
№2 / 2022
|
|
Ya.I. Ashikhmin (1), D.Yu. Schekochikhin (2)
RECOMMENDATION ON THE TREATMENT OF DYSLIPIDEMIA (ESC/EAS) 2016: FOCUS ON APPLICATION OF NON-STATIN LIPID-LOWERING THERAPY
|
№6 / 2017
|
|
Z.G. Luginova (1), O.A. Pogorelova (1), M.I. Tripoten (1), M.V. Koshurnikova (1), T.V. Kuznetsova (1), V.P. Masenko (1), Yu.G. Matchin (1), T.V. Balakhonova (1), A.V. Susekov (2)
MAIN RESULTS OF RANDOMIZED TRIAL "FREGAT"*: EFFECT OF SHORT-TERM INTENSIVE ROSUVASTATIN THERAPY ON CAROTID ATHEROSCLEROSIS IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK.
|
№18 / 2016
|
Русский
